Detail Information of Genetic Polymorphisms
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0027 Transporter Info | ||||
Gene Name | SLC22A12 | ||||
Protein Name | Urate anion exchanger 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Genetic Polymorphisms of DT (GPD) | |||||
Genetic Polymorphism | rs11231825 | ||||
Site of GPD | chr11:64592802 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | T>C | ||||
Minor Allele Frequency | C=0.3860/1933 (Global) | ||||
Genotype TT | Click to Show/Hide the Full List of Affected Drugs: 4 Drugs in Total | ||||
Cytarabine | Drug Info | Acute Myeloid Leukemia | Correlated with the increased likelihood of fever in patients (compare with genotypes CC + CT) | [ 1] | |
Fludarabine | Drug Info | Acute Myeloid Leukemia | Correlated with the increased likelihood of fever in patients (compare with genotypes CC + CT) | [ 1] | |
Gemtuzumab ozogamicin | Drug Info | Acute Myeloid Leukemia | Correlated with the increased likelihood of fever in patients (compare with genotypes CC + CT) | [ 1] | |
Idarubicin | Drug Info | Acute Myeloid Leukemia | Correlated with the increased likelihood of fever in patients (compare with genotypes CC + CT) | [ 1] | |
References | |||||
1 | Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. Pharmacogenomics J. 2013 Aug;13(4):335-41. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.